Lipocine Inc. — Director's Dealing 2014

Aug 15, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2014-08-14

Reporting Person: Venkateshwaran Srinivasan (VP RandD)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-14	Stock Option (Right to Buy)	$8.43	A	10363	Acquired	2024-08-14	Common Stock (10363)	Direct

Footnotes

F1: Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of August 14, 2014, while the remaining 2/3 of the shares subject to the award vesting monthly on a prorata basis over the following two years.